MENU

KANT

Stock ticker:

PRICE

CHANGE

CAPITALIZATION

Kineta (KANT) Ownership - Who owns Kineta?

Kineta Inc is a clinical stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients’ lives... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

4.55M

P/E Ratio

N/A

Total Cash

900K

Projected Growth

N/A

Total Debt

710K

Revenue

N/A

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash/Share

0.07

Total Debt/Equity

N/A

Revenue/Share

null USD as % of share price

View a ticker or compare two or three

VS

VS

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for KANT

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Details